Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of â¼130,000 Swedish Subjects over 14 Years.

Secnik, Juraj; Xu, Hong; Schwertner, Emilia; Hammar, Niklas; Alvarsson, Michael; Winblad, Bengt; Eriksdotter, Maria; Garcia-Ptacek, Sara; Religa, Dorota

Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of â¼130,000 Swedish Subjects over 14 Years.

Secnik, Juraj; Xu, Hong; Schwertner, Emilia; Hammar, Niklas; Alvarsson, Michael; Winblad, Bengt; Eriksdotter, Maria; Garcia-Ptacek, Sara; Religa, Dorota.

Afiliación

Secnik J; Department of Neurobiology, Center for Alzheimer Research, Division of Clinical Geriatrics, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Xu H; Department of Neurobiology, Center for Alzheimer Research, Division of Clinical Geriatrics, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Schwertner E; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Hammar N; Department of Neurobiology, Center for Alzheimer Research, Division of Clinical Geriatrics, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Alvarsson M; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Winblad B; Department of Molecular Medicine and Surgery, Growth and Metabolism, Karolinska Institutet, Stockholm, Sweden.
Eriksdotter M; Department of Neurobiology, Center for Alzheimer Research, Division of Neurogeriatrics, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Garcia-Ptacek S; Theme Aging, Karolinska University Hospital, Huddinge, Sweden.
Religa D; Department of Neurobiology, Center for Alzheimer Research, Division of Clinical Geriatrics, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.

J Alzheimers Dis ; 76(4): 1581-1594, 2020.

Article en En | MEDLINE | ID: mdl-32741836

Asunto(s)

Demencia/diagnóstico; Inhibidores de la Dipeptidil-Peptidasa IV/uso terapéutico; Hipoglucemiantes/uso terapéutico; Metformina/uso terapéutico; Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico; Compuestos de Sulfonilurea/uso terapéutico; Anciano; Anciano de 80 o más Años; Estudios de Cohortes; Demencia/inducido químicamente; Diabetes Mellitus Tipo 2/complicaciones; Quimioterapia Combinada/métodos; Femenino; Humanos; Masculino; Persona de Mediana Edad; Suecia

Palabras clave

Dementia; diabetes mellitus; hypoglycemic agents; pharmacoepidemiology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_alzheimer_other_dementias / 6_endocrine_disorders / 6_mental_health_behavioral_disorders Asunto principal: Compuestos de Sulfonilurea / Demencia / Inhibidores de la Dipeptidil-Peptidasa IV / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes / Metformina Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google